Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

New COVID-19 cases peak in Sydney as Australia battles Delta variant

Published 08/04/2021, 10:41 PM
Updated 08/05/2021, 06:15 AM
© Reuters. FILE PHOTO: Personnel from the Australian Defence Force and New South Wales Police Force patrol a street in the Bankstown suburb during an extended lockdown to curb the spread of the coronavirus disease (COVID-19) in Sydney, Australia, August 3, 2021.  RE

By Renju Jose and Colin Packham

SYDNEY (Reuters) -Sydney reported a record daily number of new coronavirus cases on Thursday and the state of Victoria announced a one-week lockdown as Australia tried to contain the highly infectious Delta variant.

With around 35,200 COVID-19 cases and 932 deaths, Australia has avoided the high caseloads of other developed countries but its vaccination figures are among the lowest, with only 20% of people aged over 16 fully vaccinated.

The government is also under pressure as Australia's A$2 trillion ($1.5 trillion) economy is threatened by a second recession in two years.

Sydney, Australia's largest city and the capital of New South Wales state, is nearing the seventh week of a nine-week lockdown. It reported five deaths and a record 262 infections in the past 24 hours.

Victoria state said it had detected eight new cases, and began its seven-day lockdown on Thursday evening.

"Nothing about this is optional. This is a lockdown, it will be enforced, for the best of reasons and the best purposes, to bring these case numbers down, under control so we can once again be open," Victoria state Premier Daniel Andrews told reporters in Melbourne.

Australia's three most populous cities - Sydney, Melbourne and Brisbane - are all in lockdown. The Hunter region in New South Wales will also be locked down from Thursday evening after six new infections there.

GET VACCINATED

Four of the five people who died of COVID-19 in Sydney were unvaccinated. The other had received one dose, state health officials said.

Many people remain wary of taking the AstraZeneca (NASDAQ:AZN) vaccine after a small number of cases of a rare blood-clotting disorder were reported among people who received it -- including a new case, that of a 34-year-old woman from New South Wales.

Many people want to wait for more supplies of the Pfizer (NYSE:PFE) vaccine to arrive next month, when Australia expects to allow people under 40 to register to be inoculated.

Health experts expect Australia to endure stop-and-start lockdowns until it reaches a high vaccination rate but lawmakers face demands to ease restrictions for those unable to work.

© Reuters. FILE PHOTO: Personnel from the Australian Defence Force and New South Wales Police Force patrol a street in the Bankstown suburb during an extended lockdown to curb the spread of the coronavirus disease (COVID-19) in Sydney, Australia, August 3, 2021.  REUTERS/Loren Elliott

"I'm a fortunate one to be in essential service, so I'm still working, still getting paid. For other people it's a mixed bag. Some people are taking it really well and others not so well," said Keirom O'Donoughue, a pharmacy salesperson in Sydney.

($1 = 1.3535 Australian dollars)

Latest comments

If countries were to learned how China handled the virus, the world would have been recovered by... instead we will continue to see flare ups and lockdowns that is not done right...
Welcome to the Globalist New World Order of Neofeudalist Totalitarianism.
I see there’s a fan of Totalitarianism.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.